Antidiabetic drugs such as metformin, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), and sodiumglucose cotransporter-2 (SGLT-2) inhibitors not only improve glycemic control but also exert favorable effects on muscle metabolism and function in individuals with T2D-related sarcopenia [115]
It is commonly studied in experimental models focused on peptide signaling, molecular interaction, and pathway activity
Your doctor might say VLDL at 28 mg/dL is fine. For disease avoidance in a metabolically sick population, maybe
Understanding the Difference What is the difference between water retention and bloating from creatine
Hussain S, Slikker WJR, Ali SF
Published in Cardiovascular Diabetology Endocrinology Reports , the study pooled data from more than 90,000 patients across 11 clinical trials and found about a 13 percent reduction in major cardiovascular events over nearly three years